Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.7.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Operating expenses:    
Research and development $ 10,449 $ 16,721
General and administrative 8,376 14,296
Litigation accrual expense 3,335
Total operating expenses 18,825 34,352
Loss from operations (18,825) (34,352)
Other (expense) income:    
Interest expense (131) (842)
Interest income 29
Other income (expense), net 125 (213)
Reorganization items, net (8,188)
Net loss (27,019) (35,378)
Other comprehensive income:    
Net unrealized gains on marketable securities 8
Comprehensive loss $ (27,019) $ (35,370)
Basic and diluted net loss per common share $ (2.78) $ (8.57)
Weighted average common shares outstanding used to calculate basic and diluted net loss per common share 9,707,877 4,125,009